Anaphylaxis
📧 Sign up to get email alerts when something new happens for Anaphylaxis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-03-30Clinical Trial Update: Study of Drug Exposure in Systemic Circulation of Primatene Mist by Oral Inhalation, Versus Epinephrine Injection by Intramuscular Injection and ProAir by Oral Inhalation in Healthy Individuals [Phase 4]
Phase 4 clinical trial comparing systemic exposure of Primatene Mist via oral inhalation to epinephrine IM injection and ProAir via oral inh…
-
FDA approval · 2020-12-24FDA Approved: EPIPEN — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for EPIPEN (epinephrine) filed by Viatris Specialty LLC.
-
FDA approval · 2020-06-17FDA Approved: EPIPEN — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Epipen (epinephrine auto-injector) from Viatris Specialty LLC. The approval covers changes appro…
-
FDA approval · 2020-04-24FDA Approved: EPINEPHRINE — Original Application (International Medication Systems, Limited)
FDA approves the original application for a generic epinephrine product from International Medication Systems, Limited (ANDA211880). The pro…
-
CLINICAL_TRIALS trial_result · 2020-04-09Clinical Trial Update: Mast Cell Activation Test in Allergic Disease
Completed clinical trial evaluating a mast cell activation test in allergic diseases; results posted in 2020.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-01-31FDA Approved: EPIPEN — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for EPIPEN (epinephrine auto-injector) from Viatris Specialty LLC.
-
FDA approval · 2019-09-28FDA Approved: AUVI-Q — Supplemental Application (kaleo, Inc)
The FDA approved a supplemental application for AUVI-Q (epinephrine) filed by Kaleo, Inc.
-
CLINICAL_TRIALS trial_result · 2019-07-01Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis [Phase 2]
Phase 2 randomized trial evaluating omalizumab versus placebo for idiopathic anaphylaxis completed; results posted in 2019.
-
FDA approval · 2019-01-29FDA Approved: ADRENALIN — Supplemental Application (Par Health USA, LLC)
The FDA approved a supplemental application for ADRENALIN (epinephrine) filed by Par Health USA, LLC.
-
FDA label_change · 2018-08-23FDA Approved: EPIPEN — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for EPIPEN (epinephrine autoinjector) from Viatris Specialty LLC, resulting in changes to the produc…
-
FDA approval · 2018-08-16FDA Approved: EPINEPHRINE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's Epinephrine generic under an Original Application, authorizing a generic epinephrine injection product.
-
CLINICAL_TRIALS trial_result · 2018-04-04Clinical Trial Update: Major Allergen in Wheat Anaphylaxis in Thai Population [NA]
A completed clinical trial from Mahidol University exploring major wheat allergen triggers for anaphylaxis in a Thai population.
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: Role of Neutrophil Activation in Anaphylaxis to Neuro-Muscular Blocking Agents
A completed clinical trial investigates the role of neutrophil activation in anaphylaxis caused by neuromuscular blocking agents.
-
FDA approval · 2017-11-17FDA Approved: AUVI-Q — Supplemental Application (kaleo, Inc)
FDA approved a supplemental application for AUVI-Q (epinephrine auto-injector) by Kaleo, Inc., indicating a regulatory action related to the…
-
CLINICAL_TRIALS trial_result · 2017-10-06Clinical Trial Update: Smartphone Apps for Pediatric Resuscitation [NA]
A completed status update for the pediatric resuscitation smartphone app trial (NCT02958605) sponsored by St. Justine's Hospital, focusing o…
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: Satisfaction of Patient With Anaphylaxis in the Use of a Medical Device [NA]
A completed clinical trial evaluating patient satisfaction with a medical device used for managing anaphylaxis.
-
FDA approval · 2017-04-28FDA Approved: EPIPEN — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Epipen (epinephrine) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS withdrawal · 2017-01-09Clinical Trial Update: Intravenous Heparin as an Adjunct for the Treatment of Anaphylactic Reactions in an Emergency Department [NA]
A clinical trial evaluating intravenous heparin as an adjunct treatment for anaphylaxis in the emergency department has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: Safety of Oral Immunotherapy for Cow's Milk Allergy in School-aged Children [Phase 4]
This Phase 4 trial update reports on the safety of oral immunotherapy for cow's milk allergy in school-aged children.
-
FDA approval · 2016-12-19FDA Approved: AUVI-Q — Supplemental Application (kaleo, Inc)
FDA approved a supplemental application for AUVI-Q (epinephrine) submitted by Kaleo, Inc.
-
FDA label_change · 2016-09-12FDA Approved: ADRENALIN — Supplemental Application (Par Health USA, LLC)
FDA approves a supplemental labeling application for Adrenalin (epinephrine) submitted by Par Health USA, LLC.
-
FDA label_change · 2016-05-18FDA Approved: EPINEPHRINE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for epinephrine from Amneal Pharmaceuticals of New York LLC, indicating a labeling change for the pr…
-
FDA approval · 2016-05-18FDA Approved: EPIPEN — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Epipen (epinephrine auto-injector) from Viatris Specialty LLC.
-
FDA approval · 2016-05-18FDA Approved: AUVI-Q — Supplemental Application (kaleo, Inc)
The FDA approved a supplemental application for AUVI-Q (epinephrine auto-injector) submitted by Kaleo, Inc.
-
FDA approval · 2016-05-18FDA Approved: EPINEPHRINE — Supplemental Application (BPI Labs, LLC)
FDA approved a supplemental application for Epinephrine from BPI Labs, LLC, indicating an addition or modification to the product’s labeling…